Φορτώνει......
Switching from Epoetin Alfa (Epogen®) to Epoetin Alfa-Epbx (Retacrit(TM)) Using a Specified Dosing Algorithm: A Randomized, Non-Inferiority Study in Adults on Hemodialysis
BACKGROUND: For patients with anemia undergoing hemodialysis, erythropoiesis-stimulating agents (ESAs) are typically dosed via precise algorithms. Using one such algorithm, we assessed the maintenance of hemoglobin levels in patients switched from epoetin alfa reference product (Epogen®) to epoetin...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | Am J Nephrol |
|---|---|
| Κύριοι συγγραφείς: | , , , , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
S. Karger AG
2018
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6214608/ https://ncbi.nlm.nih.gov/pubmed/30196301 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000492621 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|